Search Results - "Kooijmans, M F"
-
1
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite
Published in Neurology (25-11-2003)“…Visual dysfunction is one of the most common causes of disability in multiple sclerosis (MS). The Multiple Sclerosis Functional Composite (MSFC), a new…”
Get full text
Journal Article -
2
Benefit of interferon β-1a on MSFC progression in secondary progressive MS
Published in Neurology (10-09-2002)Get full text
Journal Article -
3
Benefit of interferon beta-1a on MSFC progression in secondary progressive MS
Published in Neurology (10-09-2002)“…Interferon beta-1a (IFNbeta-1a, Avonex) is efficacious in relapsing forms of MS. Studies of other IFNbeta preparations in secondary progressive MS (SPMS)…”
Get full text
Journal Article -
4
A randomized, double-blind, dose-comparison study of weekly interferon β-1a in relapsing MS
Published in Neurology (26-11-2002)Get full text
Journal Article -
5
Interstitial rejection, vascular rejection, and diffuse thrombosis of renal allografts : Predisposing factors, histology, immunohistochemistry, and relation to outcome
Published in Transplantation (15-05-1996)“…Histological and immunohistochemical analyses were made of biopsy specimens from 50 consecutive patients who experienced putative graft rejection. The mean age…”
Get full text
Journal Article -
6
Evaluation by histology, immunohistology and PCR of protocollized renal biopsies 1 week post-transplant in relation to subsequent rejection episodes
Published in Nephrology, dialysis, transplantation (1995)“…Renal biopsies were performed 1 week following renal transplantation at a time without clinical evidence of rejection in 43 patients (13 females, mean age 48…”
Get more information
Journal Article -
7
-
8
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial
Published in Archives of neurology (Chicago) (01-06-2001)“…The Multiple Sclerosis Functional Composite (MSFC) is a multidimensional clinical outcome measure that includes quantitative tests of leg function/ambulation…”
Get more information
Journal Article -
9
A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS
Published in Neurology (26-11-2002)“…Interferon beta-1a (IFNbeta-1a; Avonex) is effective for the treatment of relapsing MS; however, the optimal dose of IFNbeta-1a is not known. To determine…”
Get full text
Journal Article -
10
Infectious arthritis caused by Propionibacterium acnes: a report of two cases
Published in Annals of the rheumatic diseases (01-10-1989)“…Propionibacterium acnes, a micro-organism with low pathogenicity, rarely causes arthritis in a joint without a prosthesis. This report deals with two cases of…”
Get full text
Journal Article -
11
Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group
Published in Annals of neurology (01-12-2000)“…Cognitive dysfunction is common in multiple sclerosis (MS), yet few studies have examined effects of treatment on neuropsychological (NP) performance. To…”
Get full text
Journal Article -
12
Dietary fish oil in renal transplant recipients treated with cyclosporin-A: no beneficial effects shown
Published in Journal of the American Society of Nephrology (01-03-1996)“…This study aimed to determine whether dietary supplementation with fish oil has a beneficial effect on graft function and the incidence of rejection in renal…”
Get full text
Journal Article -
13
-
14
Infectious arthritis caused by Propionibacterium acnes (a report of two cases)
Published in Annals of the rheumatic diseases (1989)Get full text
Journal Article